+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

South Korea Metabolic Disorders Market Outlook to 2036 - Diabetes Assays and Cholesterol Tests

  • PDF Icon

    Report

  • 53 Pages
  • May 2026
  • Region: South Korea
  • GlobalData
  • ID: 6108290

South Korea Metabolic Disorders Market Outlook to 2036 - Diabetes Assays and Cholesterol Tests

Summary

The analyst’s “South Korea Metabolic Disorders Market Outlook to 2036” is a comprehensive databook report, covering key market data on the South Korea Metabolic Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Diabetes Assays, Cholesterol Tests

The South Korea Metabolic Disorders Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Metabolic Disorders Market.
  • Global corporate-level profiles of key companies operating within the South Korea Metabolic Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

South Korea Metabolic Disorders is segmented as follows:

  • Diabetes Assays
  • Cholesterol Tests

Reasons to Buy

The South Korea Metabolic Disorders Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Metabolic Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Metabolic Disorders Market, South Korea
2.1 Metabolic Disorders Market, South Korea, Revenue ($m), 2024-2036
2.1.1 Cholesterol Tests Market, South Korea, Revenue ($m), by Segment, 2024-2036
2.1.2 Diabetes Assays Market, South Korea, Revenue ($m), by Segment, 2024-2036
2.2 Metabolic Disorders Market, South Korea, Volume (Units), 2024-2036
2.2.1 Cholesterol Tests Market, South Korea, Volume (Units), by Segment, 2024-2036
2.2.2 Diabetes Assays Market, South Korea, Volume (Units), by Segment, 2024-2036
2.3 Metabolic Disorders Market, South Korea, Average Price ($), 2024-2036
2.4 Metabolic Disorders Market, South Korea, Company Share by Revenue ($m), 2025
3 Metabolic Disorders Market Pipeline Products
3.1 Metabolic Disorders Market Pipeline Products
3.2 Metabolic Disorders - Pipeline Products by Stage of Development
3.3 Metabolic Disorders - Pipeline Products by Segment
3.4 Metabolic Disorders - Pipeline Products by Territory
3.5 Metabolic Disorders - Pipeline Products by Regulatory Path
3.6 Metabolic Disorders - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in South Korea, Metabolic Disorders Market
4.1 Siemens Healthineers AG
4.1.1 Company Overview
4.2 Roche Diagnostics International Ltd
4.2.1 Company Overview
4.3 Beckman Coulter Inc
4.3.1 Company Overview
4.4 Abbott Laboratories
4.4.1 Company Overview
5 Recent Developments
5.1 Product News
5.1.1 Sep 19, 2025: Boditech Med Launches Advanced Diabetes Diagnostics at EASD 2025
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Metabolic Disorders Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 2: Cholesterol Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 3: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 4: Metabolic Disorders Market, South Korea, Volume (Units), 2024-2036
Table 5: Cholesterol Tests Market, South Korea, Volume (Units), 2024-2036
Table 6: Diabetes Assays Market, South Korea, Volume (Units), 2024-2036
Table 7: Metabolic Disorders Market, South Korea, Average Price ($), 2024-2036
Table 8: Metabolic Disorders Market, South Korea, Company Share by Revenue ($m), USD Constant, 2025
Table 9: Metabolic Disorders Market Pipeline Products
Table 10: Metabolic Disorders - Pipeline Products by Stage of Development
Table 11: Metabolic Disorders Companies - Pipeline Products by Stage of Development
Table 12: Metabolic Disorders - Pipeline Products by Segment
Table 13: Metabolic Disorders - Pipeline Products by Territory
Table 14: Metabolic Disorders - Pipeline Products by Regulatory Path
Table 15: Metabolic Disorders - Pipeline Products by Estimated Approval Date
Table 16: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Metabolic Disorders Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cholesterol Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 3: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 4: Metabolic Disorders Market, South Korea, Volume (Units), 2024-2036
Figure 5: Cholesterol Tests Market, South Korea, Volume (Units), 2024-2036
Figure 6: Diabetes Assays Market, South Korea, Volume (Units), 2024-2036
Figure 7: Metabolic Disorders Market, South Korea, Company Share (%), 2025
Figure 8: Metabolic Disorders - Pipeline Products by Stage of Development
Figure 9: Metabolic Disorders - Pipeline Products by Segment
Figure 10: Metabolic Disorders - Pipeline Products by Territory
Figure 11: Metabolic Disorders - Pipeline Products by Regulatory Path
Figure 12: Metabolic Disorders - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Siemens Healthineers AG
  • Roche Diagnostics International Ltd
  • Beckman Coulter Inc
  • Abbott Laboratories